This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 May 21;2(1):16.

doi: 10.1186/s43556-021-00042-3.

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy

Affiliations

Affiliations

¹ Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China. yuxun_wang@yahoo.com.
² Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China.

PMID: 35006462
PMCID: PMC8607363
DOI: 10.1186/s43556-021-00042-3

Published Erratum

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy

Yuxun Wang et al. Mol Biomed. 2021.

. 2021 May 21;2(1):16.

doi: 10.1186/s43556-021-00042-3.

Authors

Affiliations

¹ Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China. yuxun_wang@yahoo.com.
² Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China.

PMID: 35006462
PMCID: PMC8607363
DOI: 10.1186/s43556-021-00042-3

No abstract available

PubMed Disclaimer

Erratum for

Development of a novel TLR8 agonist for cancer immunotherapy.
Wang Y, Yang H, Li H, Zhao S, Zeng Y, Zhang P, Lin X, Sun X, Wang L, Fu G, Gao Y, Wang P, Gao D. Wang Y, et al. Mol Biomed. 2020 Sep 10;1(1):6. doi: 10.1186/s43556-020-00007-y. Mol Biomed. 2020. PMID: 35006413 Free PMC article.

Similar articles

Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ, Scott EA, Scheid A, Bergelson I, Joshi S, Pietrasanta C, Brightman S, Sanchez-Schmitz G, Van Haren SD, Ninković J, Kats D, Guiducci C, de Titta A, Bonner DK, Hirosue S, Swartz MA, Hubbell JA, Levy O. Dowling DJ, et al. J Allergy Clin Immunol. 2017 Nov;140(5):1339-1350. doi: 10.1016/j.jaci.2016.12.985. Epub 2017 Mar 23. J Allergy Clin Immunol. 2017. PMID: 28343701 Free PMC article.
Development of a novel TLR8 agonist for cancer immunotherapy.
Wang Y, Yang H, Li H, Zhao S, Zeng Y, Zhang P, Lin X, Sun X, Wang L, Fu G, Gao Y, Wang P, Gao D. Wang Y, et al. Mol Biomed. 2020 Sep 10;1(1):6. doi: 10.1186/s43556-020-00007-y. Mol Biomed. 2020. PMID: 35006413 Free PMC article.
[Expression of TLR8 in human cervical cancer HeLa cells and the effect of TLR8 agonist on the cell proliferation and apoptosis].
Yang H, He ZQ, Zhao YX, Wang KW, Zheng D, Su ZL, Tong J, Ma J, Wang SJ, Xu HX. Yang H, et al. Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):643-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340042 Chinese.
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
Smits EL, Ponsaerts P, Berneman ZN, Van Tendeloo VF. Smits EL, et al. Oncologist. 2008 Aug;13(8):859-75. doi: 10.1634/theoncologist.2008-0097. Epub 2008 Aug 13. Oncologist. 2008. PMID: 18701762 Review.
[Structural Analyses of Toll-like Receptor Sensing Single-stranded Nucleic Acids and Its Application].
Shimizu T. Shimizu T. Yakugaku Zasshi. 2016;136(2):173-8. doi: 10.1248/yakushi.15-00229-1. Yakugaku Zasshi. 2016. PMID: 26831789 Review. Japanese.

See all similar articles

References

1. Wang Y, Yang H, Li H, Zhao S, Zeng Y, Zhang P, Lin X, Sun X, Wang L, Fu G, Gao Y, Wang P, Gao D. Development of a novel TLR8 agonist for cancer immunotherapy. Mol Biomed. 2020;1(1):6. doi: 10.1186/s43556-020-00007-y. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal